Baader Bank Aktiengesellschaft Has $541,000 Position in DocuSign, Inc. (NASDAQ:DOCU)

Baader Bank Aktiengesellschaft decreased its holdings in shares of DocuSign, Inc. (NASDAQ:DOCU) by 50.6% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 6,011 shares of the company’s stock after selling 6,153 shares during the period. Baader Bank Aktiengesellschaft’s holdings in DocuSign were worth $541,000 as of its most recent SEC filing.

A number of other large investors have also recently made changes to their positions in DOCU. Itau Unibanco Holding S.A. acquired a new stake in shares of DocuSign in the 3rd quarter worth about $28,000. Brooklyn Investment Group bought a new stake in DocuSign during the 3rd quarter worth approximately $33,000. Modus Advisors LLC purchased a new stake in shares of DocuSign in the fourth quarter worth approximately $36,000. Reston Wealth Management LLC bought a new position in shares of DocuSign in the third quarter valued at approximately $47,000. Finally, Avior Wealth Management LLC boosted its position in shares of DocuSign by 36.5% during the fourth quarter. Avior Wealth Management LLC now owns 542 shares of the company’s stock valued at $49,000 after buying an additional 145 shares during the last quarter. 77.64% of the stock is owned by institutional investors.

DocuSign Price Performance

Shares of NASDAQ DOCU opened at $95.85 on Friday. The stock has a market capitalization of $19.36 billion, a PE ratio of 19.76, a P/E/G ratio of 8.30 and a beta of 0.88. DocuSign, Inc. has a one year low of $48.70 and a one year high of $107.86. The business’s fifty day moving average price is $90.73 and its 200-day moving average price is $72.41.

Insider Buying and Selling at DocuSign

In related news, CEO Allan C. Thygesen sold 7,763 shares of DocuSign stock in a transaction that occurred on Monday, December 2nd. The shares were sold at an average price of $80.54, for a total value of $625,232.02. Following the completion of the transaction, the chief executive officer now directly owns 100,062 shares in the company, valued at approximately $8,058,993.48. The trade was a 7.20 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director Daniel D. Springer sold 581,588 shares of the stock in a transaction on Tuesday, December 10th. The stock was sold at an average price of $97.04, for a total value of $56,437,299.52. Following the sale, the director now owns 906,430 shares in the company, valued at approximately $87,959,967.20. This represents a 39.08 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 685,773 shares of company stock valued at $66,032,726 over the last three months. 1.66% of the stock is currently owned by insiders.

Analyst Ratings Changes

DOCU has been the subject of a number of analyst reports. JMP Securities reissued a “market outperform” rating and issued a $124.00 price target on shares of DocuSign in a research report on Tuesday, January 7th. Wells Fargo & Company raised their price target on shares of DocuSign from $50.00 to $70.00 and gave the company an “underweight” rating in a research report on Friday, December 6th. Citigroup upped their price objective on shares of DocuSign from $87.00 to $113.00 and gave the stock a “buy” rating in a research report on Friday, December 6th. Hsbc Global Res upgraded DocuSign to a “moderate sell” rating in a research note on Friday, December 6th. Finally, Needham & Company LLC reaffirmed a “hold” rating on shares of DocuSign in a research report on Friday, December 6th. Three equities research analysts have rated the stock with a sell rating, seven have assigned a hold rating and three have assigned a buy rating to the company. According to MarketBeat, the company presently has an average rating of “Hold” and an average target price of $92.45.

About DocuSign

DocuSign, Inc provides electronic signature solution in the United States and internationally. The company provides e-signature solution that enables sending and signing of agreements on various devices; Contract Lifecycle Management (CLM), which automates workflows across the entire agreement process; Document Generation streamlines the process of generating new, custom agreements; and Gen for Salesforce, which allows sales representatives to automatically generate agreements with a few clicks from within Salesforce.